Welcome to our dedicated page for Kewaunee Scienti SEC filings (Ticker: KEQU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching for details on Kewaunee Scientific’s latest laboratory furniture contracts or wondering how steel prices affect its margins? This SEC filings hub brings every disclosure together, so you can move from question to insight in minutes.
Start with the Kewaunee Scientific annual report 10-K simplified section: our AI pinpoints backlog shifts, segment revenue from fume hoods vs. modular systems, and geographic risk factors—no need to scan 200 pages. Prefer quarter-to-quarter trends? The Kewaunee Scientific quarterly earnings report 10-Q filing page pairs raw numbers with narrative summaries that highlight material cost swings and project pipeline updates.
Real-time alerts keep you ahead of ownership moves. Track Kewaunee Scientific insider trading Form 4 transactions the moment they hit EDGAR. Our dashboard also groups Kewaunee Scientific Form 4 insider transactions real-time by executive, making it easy to spot buying before key bids or product launches.
Need context on sudden announcements? The platform’s AI explains every Kewaunee Scientific 8-K material events explained entry—from facility shutdowns to leadership changes—in plain language. For governance aficionados, the Kewaunee Scientific proxy statement executive compensation tab links pay packages to performance metrics, while AI flags noteworthy changes in option grants.
Across all filings you’ll see quick links like “understanding Kewaunee Scientific SEC documents with AI” and “Kewaunee Scientific earnings report filing analysis,” designed for analysts, portfolio managers, and supply-chain watchers alike. Every document is time-stamped, searchable, and supported by concise AI-powered summaries that turn dense disclosures into clear action points.
Kewaunee Scientific Corp. (KEQU) – Form 4 filed 07/28/2025 reports two open-market sales by CFO Donald T. Gardner III on 07/24/2025.
- Sold 2,096 common shares at a weighted avg. $58.34 (range $58.00-$58.97).
- Sold 904 common shares at a weighted avg. $59.18 (range $59.00-$59.45).
- Total shares sold: 3,000; estimated proceeds ≈ $175k.
- Direct ownership dropped from 17,564 to 14,564 shares, a reduction of roughly 17%.
No derivative transactions were reported and the filing offers no commentary on the purpose of the sales.
Kewaunee Scientific Corp. (KEQU) – Form 144 filing: an unidentified insider intends to sell up to 3,000 common shares through Fidelity Brokerage Services on or about 07/23/2025 via Nasdaq. At the recent reference price, the proposed sale is valued at $174,750.
The company has 2,844,290 shares outstanding, so the sale represents roughly 0.1 % of total shares. The seller acquired the stock on 06/23/2023 as a stock-award compensation; no cash purchase was involved, and there have been no other sales in the past three months. The filer certifies that no non-public, material adverse information is known.
While Form 144 notices are routine, any insider disposition can influence sentiment. Given the small size relative to float and absence of other sales, the filing is unlikely to be materially impactful for KEQU’s fundamentals.
FAQ
What is the current stock price of Kewaunee Scienti (KEQU)?
What is the market cap of Kewaunee Scienti (KEQU)?
